🇺🇸 FDA
Patent

US 8795677

Treatment methods using an F1-V plague vaccine

granted A61PA61P31/04A61P37/04

Quick answer

US patent 8795677 (Treatment methods using an F1-V plague vaccine) held by The United States of America as represented by the Secretary of the Army expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Aug 05 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61P, A61P31/04, A61P37/04